Can you provide the last earnings date for REVELATION BIOSCIENCES INC?
REVELATION BIOSCIENCES INC (REVB) last reported earnings on 2/26/2026.
NASDAQ:REVB • US76135L8046
Past quarterly earnings results for REVELATION BIOSCIENCES INC (REVB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -23.95 | -3.73 | -541.54% | 59.92% | - | - | ||
| Q3 2025 | -7.08 | -5.45 | -29.98% | 95.61% | - | - | ||
| Q2 2025 | -28.04 | -18.18 | -54.27% | 97.15% | - | - | ||
| Q1 2025 | -25.32 | -84.21 | 69.93% | 94.64% | - | - | ||
| Q4 2024 | -59.76 | -66.59 | 10.25% | 96.26% | - | - | ||
| Q3 2024 | -161.28 | -556.19 | 71.00% | 93.33% | - | - | ||
| Q2 2024 | -984.96 | -353.49 | -178.64% | 31.60% | - | - | ||
| Q1 2024 | -472.32 | -1,054.60 | 55.21% | -102.94% | - | - | ||
| Q4 2023 | -1,599.36 | -2,696.72 | 40.69% | 84.31% | - | - | ||
| Q3 2023 | -2,419.20 | -1,762.56 | -37.25% | 80.00% | - | - | ||
| Q2 2023 | -1,440.00 | -2,350.08 | 38.73% | 94.05% | - | - | ||
| Q1 2023 | 16,070.40 | -3,818.88 | 520.81% | 116.96% | - | - | ||
| Q4 2022 | -10,195.20 | -10,281.60 | 0.84% | - | - | - | ||
| Q3 2022 | -12,096.00 | -18,506.88 | 34.64% | - | - | - | ||
| Q2 2022 | -24,192.00 | -28,788.48 | 15.97% | - | - | - | ||
| Q1 2022 | -94,752.00 | -28,788.48 | -229.13% | - | - | - | ||
| Q4 2021 | - | - | - | - | ||||
| Q3 2021 | - | - | - | - | ||||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - |
Notes
REVELATION BIOSCIENCES INC (REVB) last reported earnings on 2/26/2026.
REVELATION BIOSCIENCES INC (REVB) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, REVELATION BIOSCIENCES INC (REVB) has beaten EPS estimates in 1 out of 4 releases.